 |
| iFOB Test |
| Hemosure® is the latest advanced technological breakthrough in Immunological Fecal Occult Blood Testing (iFOBT), which is approved, by the Food and Drug Administration (FDA) and is also CLIA waived. We offer various kits that are configured to best suit your department needs. Our test is most cost effective test in the market today! |
|
|
|
 |
| HemoSure Fecal Occult Blood Test (30 Pack) |
| Fecal Occult Blood Test (FOBT), Hemosure is a sandwich dye conjugate immunoassay to selectively identify human hemoglobin in test samples with a high degree of sensitivity and specificity. This test is CLIA waived and FDA approved-HemoSure Fecal Occult Blood Test. |
|
|
|
 |
| Hemoccult® Fecal Occult Blood Test |
| For thirty years, the Hemoccult® fecal occult blood test (FOBT) has been aiding physicians in detecting hidden blood in stool specimens as an early indication of colorectal cancer. More than 300 studies using Hemoccult¨ products many of which were conducted over long periods of time with large numbers of participants- have been published in leading medical journals around the world. As a result of these studies, the American Cancer Society and other healthcare and medical agencies now recommend |
|
|
|
 |
| Hemoccult® ICT |
| Hemoccult® ICT is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs. Because of its superior specificity for lower GI bleeding, Hemoccult® ICT is an ideal colorectal cancer (CRC) screening tool. Higher specificity reduces the number of false positive test results, thus reducing the number of needless colonoscopies. Hemoccult® ICT is patient friendly, as there are no diet or drug restrictions for patients, which helps increase patient |
|
|
|
|
|
 |
| Primary Care (Rapid Test Kits) |
| Hemoccult® ICT is the most advanced FOBT in the Hemoccult product line. As an immunochemical FOBT (iFOBT), it has high specificity and sensitivity and it is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based FOBTs. An ideal screening tool for colorectal cancer, Hemoccult ICT does not require drug or diet restrictions on the part of the patient. |
|
|
|